Keyword: Amgen

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

Sanofi and Regeneron Appeal Praluent Sales Halt

11.01.2017 - French drugmaker Sanofi and US marketing partner Regeneron have announced they will appeal a ruling by a US federal district court judge that would prevent them from selling their...

Markets & Companies

Best Pharma Brands

08.09.2016 - Global brand agency Interbrand has identified the top 10 pharmaceutical brands among the top 25 global pharmaceutical companies. Besides the financial value of the brand, its...

News

EU Clears Amgen’s Kyprolis Cancer Therapy

06.07.2016 - European regulators have approved the use of Amgen’s cancer drug Kyprolis in combination with just dexamethasone to treat certain adults with multiple myeloma, an incurable blood...

News

Lilly-backed Study Confirms Evacetrapib Fail

05.04.2016 - Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...

News

Regeneron and Sanofi to Appeal Patent Decision

18.03.2016 - Drugmakers Regeneron Pharmaceuticals and Sanofi have said they will appeal a decision by a US federal jury that their cholesterol drug Praluent (alirocumab) infringes patents owned...

News

Patheon and Amgen in Toll Manufacturing Pact

15.03.2016 - US contract drug development and manufacturing services provider Patheon has signed a toll production agreement with leading biotechnology company Amgen. The US firms are based at...

News

FDA Won’t Widen US Merck's Zetia, Vytorin Use

19.02.2016 - By a vote of ten to five, an advisory panel of the US Food and Drug Administration (FDA) has rejected an application by Merck & Co of the US to widen the indication of its...